Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma
NCT02849158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2023-12-04
Summary
Single center interventional study to explore activity of fibroblasts in the tumor and away in the healthy rectal tissue.
Conditions
- Rectum Adenocarcinoma
Interventions
- OTHER
-
Biopsy
Rectoscopy with biopsy
Sponsors & Collaborators
-
Institut Curie
lead OTHER
Principal Investigators
-
Pascale MARIANI, LDD · Institut Curie
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-09
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- France
Study Locations
More Related Trials
-
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
NCT05496491 ·Status: RECRUITING ·Phase: NA
-
Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer
NCT00597311 ·Status: UNKNOWN ·Phase: PHASE3
-
Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
NCT05772481 ·Status: UNKNOWN
-
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
NCT04287400 ·Status: RECRUITING
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer
NCT05479240 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer
NCT03466424 ·Status: RECRUITING
-
Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer
NCT01648894 ·Status: COMPLETED ·Phase: PHASE3
-
Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
NCT07161115 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
NCT05176964 ·Status: RECRUITING
-
The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer
NCT04411524 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer
NCT02353858 ·Status: COMPLETED ·Phase: PHASE2
-
Resource-Sparing Curative Treatment for Rectal Cancer
NCT01459328 ·Status: UNKNOWN ·Phase: PHASE3
-
Watch and Wait as Treatment for Patients With Rectal Cancer
NCT03125343 ·Status: RECRUITING ·Phase: NA
-
Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer.
NCT01814969 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer
NCT06883084 ·Status: ENROLLING_BY_INVITATION
-
Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer
NCT02484040 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas
NCT01619696 ·Status: TERMINATED ·Phase: PHASE2
-
Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06761287 ·Status: RECRUITING ·Phase: NA
-
Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer
NCT01186081 ·Status: COMPLETED ·Phase: PHASE3
-
Timing of Rectal Cancer Resection After Preoperative Chemoradiotherapy
NCT02441153 ·Status: COMPLETED
-
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
NCT00835055 ·Status: WITHDRAWN
-
Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody
NCT06014944 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy
NCT02490709 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
NCT06017583 ·Status: RECRUITING ·Phase: PHASE3